Midgard Science

PreviPharma GmbH

Mannheim, Germany previpharma.com

From their website, Nov 2026

Work here? Claim this listing

About

PreviPharma GmbH is a research and manufacturing partner for the plasma fractionation industry. It supports projects across the R&D supply chain, from early research and analytical development to GMP-compliant manufacturing and life-cycle management. The company is based in Mannheim, Germany.

Services

  • Research services

    Supports projects across the plasma fractionation R&D value chain, from early-stage research and clinical study guidance through production process support and life-cycle management.

  • Strategic research support

    Provides guidance for target validation, mode of action analysis, and candidate selection, with close integration to in-vivo programs.

  • Process development and optimization

    Develops and optimizes plasma protein processes from source materials through product formation, including chromatographic, filtration, fractionation, and formulation steps.

  • Analytical method development and implementation

    Develops, qualifies, and implements analytical methods, including matrix evaluation, feasibility assessment, method optimization, bridging studies, and preparation for regulatory validation.

  • Preclinical capabilities and expertise

    Provides in-vitro and in-vivo research support, including screening, mechanistic studies, translational research, and regulated preclinical development.

    ADME, DMPK & toxicology

  • Manufacturing of plasma proteins

    Produces research-grade, GLP-tox-compliant, and GMP-compliant plasma protein material, with up- and downscaling and contract manufacturing support.

    CDMO: development & manufacturing

  • End-to-end quality

    Maintains integrated quality systems, SOPs, documentation, traceability, audits, and data-integrity processes across research, development, and manufacturing work.

  • Process Development & Optimization

    Supports process development and optimization for existing and novel proteins, including formulation and novel fractionation technologies.

  • Preclinical & Clinical Capabilities & Expertise

    Offers in-vitro analytics, in-vivo studies, clinical study planning and guidance, and pathogen safety studies.

    ADME, DMPK & toxicology

  • Development & Execution of Analytical Methods

    Designs, validates, and executes analytical methods, including advanced diagnostics.

What to send
Patient samples and data

Capabilities

Assays and studies
Process development · Toxicology · Cell-based assays · Biochemical assays · In-vitro analytics · In-vivo studies · Clinical studies · Pathogen safety studies · Diagnostic studies · Method development · Validation · Purity assessment
9 moreIdentity confirmation · Impurity quantification · Aggregation analysis · Stability profiling · Fragmentation studies · Target validation · Mode of Action (MoA) analysis · Advanced testing · Advanced diagnostics
Scale and capacity
Up to 30 liters · Up to 100 liters · Batch chromatography 1 mL to 10 L column volume · Filtration areas from 0.0073 m² to 0.1 m² · Filter presses frame width 10–30 cm · Up to 300 liters · 100 L · Future expansion projected up to 2,000 liters
Therapeutic areas
Plasma fractionation · Plasma protein therapies

Instruments and platforms

  • Nanofiltration (NF)
  • PCC
  • SMB
  • TFF

Modalities and species

Modalities
Plasma proteins · Plasma-derived proteins · Existing proteins · Novel proteins · Plasma fractionation products

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: manufacturing

  • GLPSelf-reported

    Scope: material

Industries served

  • Plasma fractionation industry
  • Pharmaceutical

Company

Type
CRDMO

Locations

Based in
Mannheim, Germany
Sites
Mannheim, Germany
Serves
international

Contacts

Similar labs

Work here? Claim this listing